Author Archives for Client Pharma

Pharmaceutical Forecasting: Supply and Demand

by

March 21, 2022 9:04 am | Leave your thoughts


Clinical trial supply services and solutions

Supply and demand of pharmaceuticals are mutually exclusive. The supply chain is wholly reliant upon pharmaceutical companies being able to effectively forecast demand for a particular product. The process of forecasting is often made difficult when a new medicine has just been brought to market or rapid deployment of a drug needs to happen in



New Appointment for Client-Pharma

by

September 3, 2018 10:19 am | Leave your thoughts


Clinical trial supply services and solutions

Client-Pharma Ltd are pleased to announce the appointment of Andrea Chopek to its Senior Management Team as President, North America effective 01 September 2018 Andrea is a highly experienced Pharma executive, having held pivotal senior roles delivering client centric philosophies for two decades and has a strong reputation for integrity and results within the pharmaceutical



Importing Comparator Drugs: 3 Questions You Need to Ask

by

March 18, 2018 1:20 pm | Leave your thoughts



It’s important to understand the markets in which you are going to conduct your clinical trial; being clear on what sources of investigational products you want to use will allow for crucial importation/supply planning activates; getting this right early is key for avoiding unwanted and costly delays later on. Are you aware of regulations for



Counterfeit Meds: What is Being Done to Fight the Problem?

by

January 12, 2018 5:13 pm | Leave your thoughts



Counterfeit medication is a billion-pound industry that affects hundreds of thousands of people around the world every year. The number of illegitimate and counterfeit medicines across the globe is becoming increasingly concerning, as they have even been appearing in the legitimate medical supply chain. Between 2011 and 2015, drug counterfeiting around the world increased by



How is Automation Helping to Optimise Clinical Trials?

by

December 16, 2017 9:22 am | Leave your thoughts


Clinical trial supply services and solutions

Clinical trials are growing increasingly complex, which means they’re likely to cost more and take up a lot of time for professionals and patients alike. The average clinical phase duration of drug development is now estimated at 6.8 years, a 15% increase over levels observed 10 years ago. Technological advances and the inclusion of more



The Future of Clinical Trials – What Can We Predict?

by

September 10, 2017 8:59 am | Leave your thoughts



Clinical trials are constantly evolving, with more data being collected in reflection to an increasingly complex environment. New technology, regulations, legislation and reforms in the pharmaceutical sector result in an environment that is always evolving. What does the future hold for clinical trials and what changes can we expect? Siteless Clinical Trials Siteless clinical trials



How Will Reforms Change the Landscape of China’s Clinical Trials?

by

August 7, 2017 2:25 pm | Leave your thoughts



China’s central government have introduced reforms in response to an increasingly challenging regulatory environment. These are likely to benefit medicine access as well as drug development, affecting those looking into China’s pharmaceutical market, which is the second largest in the world. In a long-awaited response to feedback from the local and international pharmaceutical industry, the



Best Practices for Successful Clinical Supply

by

July 16, 2017 2:02 pm | Leave your thoughts


Clinical trial supply services and solutions

The demands of clinical trial supply are constantly evolving, with the industry moving towards ever-more-elaborate studies and adaptive clinical trial designs. The progressive developments created by such factors can cause challenges for the clinical supply chain; so, when it comes to managing your global clinical supplies, it’s vital to choose a partner who sticks to



How Will Brexit Affect Clinical Trials?

by

July 4, 2017 3:28 pm | Leave your thoughts



Now that the UK has triggered Article 50, an important topic on many minds is how Britain’s exit from the European Union will affect clinical trials. Could Brexit benefit clinical trials? It is believed by some that the EU clinical trials directive has slowed the pace of research Britain has performed over the years and



1 2 3